Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 434.60
+0.20 (0.05%)
Aug 25, 2025, 4:39 PM IDT
Evogene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 9.44 | 8.51 | 5.64 | 1.68 | 0.93 | 1.04 | Upgrade | |
Revenue Growth (YoY) | -0.05% | 50.90% | 236.72% | 80.11% | -10.58% | 38.11% | Upgrade |
Cost of Revenue | 3.69 | 2.68 | 1.69 | 0.91 | 0.77 | 0.57 | Upgrade |
Gross Profit | 5.75 | 5.83 | 3.95 | 0.77 | 0.16 | 0.47 | Upgrade |
Selling, General & Admin | 9.91 | 10.87 | 9.68 | 10.42 | 9.99 | 7.99 | Upgrade |
Research & Development | 14.94 | 16.65 | 20.78 | 20.79 | 21.13 | 17.29 | Upgrade |
Other Operating Expenses | -0.19 | 0.52 | - | -3.5 | - | - | Upgrade |
Operating Expenses | 24.66 | 28.04 | 30.46 | 27.71 | 31.12 | 25.28 | Upgrade |
Operating Income | -18.9 | -22.21 | -26.51 | -26.94 | -30.95 | -24.81 | Upgrade |
Interest Expense | -0.93 | -0.06 | -0.12 | -0.17 | -0.32 | -0.24 | Upgrade |
Interest & Investment Income | 0.96 | 0.96 | 1.25 | 0.18 | 0.29 | 0.23 | Upgrade |
Earnings From Equity Investments | -0.09 | -0.04 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -0.05 | -0.05 | -0.25 | -1.74 | 1.07 | 1.01 | Upgrade |
Other Non Operating Income (Expenses) | 4.59 | 3.36 | -0.16 | -0.25 | -0.46 | -2.33 | Upgrade |
EBT Excluding Unusual Items | -14.42 | -18.04 | -25.78 | -28.92 | -30.37 | -26.14 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 0.05 | -0.72 | -0.06 | -0.03 | Upgrade |
Other Unusual Items | -1.46 | -0 | -0.25 | -0.11 | - | - | Upgrade |
Pretax Income | -15.89 | -18.05 | -25.99 | -29.75 | -30.43 | -26.17 | Upgrade |
Income Tax Expense | 0.01 | 0.01 | -0.03 | 0.09 | 0.01 | 0.03 | Upgrade |
Earnings From Continuing Operations | -15.9 | -18.05 | -25.95 | -29.84 | -30.45 | -26.21 | Upgrade |
Minority Interest in Earnings | 1.64 | 1.57 | 2.08 | 3.21 | 2.65 | 2.83 | Upgrade |
Net Income | -14.25 | -16.49 | -23.88 | -26.64 | -27.79 | -23.37 | Upgrade |
Net Income to Common | -14.25 | -16.49 | -23.88 | -26.64 | -27.79 | -23.37 | Upgrade |
Shares Outstanding (Basic) | 7 | 6 | 5 | 4 | 4 | 3 | Upgrade |
Shares Outstanding (Diluted) | 7 | 6 | 5 | 4 | 4 | 3 | Upgrade |
Shares Change (YoY) | 32.58% | 24.14% | 10.80% | 2.44% | 43.59% | 9.34% | Upgrade |
EPS (Basic) | -2.14 | -2.89 | -5.20 | -6.43 | -6.87 | -8.30 | Upgrade |
EPS (Diluted) | -2.14 | -2.89 | -5.20 | -6.43 | -6.87 | -8.30 | Upgrade |
Free Cash Flow | -18.2 | -20.33 | -22.36 | -24.85 | -25.56 | -20.2 | Upgrade |
Free Cash Flow Per Share | -2.73 | -3.57 | -4.87 | -6.00 | -6.32 | -7.17 | Upgrade |
Gross Margin | 60.93% | 68.48% | 70.00% | 45.73% | 17.53% | 44.81% | Upgrade |
Operating Margin | -200.17% | -260.96% | -470.00% | -1608.42% | -3328.28% | -2385.96% | Upgrade |
Profit Margin | -150.92% | -193.69% | -423.39% | -1590.33% | -2988.49% | -2247.50% | Upgrade |
Free Cash Flow Margin | -192.73% | -238.82% | -396.49% | -1483.52% | -2748.71% | -1941.92% | Upgrade |
EBITDA | -17.33 | -20.5 | -24.7 | -24.36 | -28.72 | -22.09 | Upgrade |
EBITDA Margin | -183.48% | -240.90% | - | - | - | - | Upgrade |
D&A For EBITDA | 1.58 | 1.71 | 1.81 | 2.58 | 2.23 | 2.73 | Upgrade |
EBIT | -18.9 | -22.21 | -26.51 | -26.94 | -30.95 | -24.81 | Upgrade |
EBIT Margin | -200.17% | -260.96% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.